Artificial intelligence for multi-time-point arterial phase contrast-enhanced MRI profiling to predict prognosis after transarterial chemoembolization in hepatocellular carcinoma.
AI enhances prognosis prediction in HCC post-TACE with 0.92 AUC accuracy. Key findings from PubMed article. 📊🧠
